메뉴 건너뛰기




Volumn 16, Issue 6, 2006, Pages 452-465

On the potential of thioredoxin reductase inhibitors for cancer therapy

Author keywords

Cancer; Chemotherapy; Inhibitor; Redox sensitivity; Thioredoxin reductase

Indexed keywords

1,2 [BIS(1,2 BENZISOSELENAZOLONE 3(2H) KETONE)]ETHANE; 1,4 NAPHTHOQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATIC NITRO COMPOUND; AURANOFIN; AUROTHIOGLUCOSE; CARMUSTINE; CHALCOGEN; CISPLATIN; CURCUMIN; DEATH RECEPTOR 4; DEATH RECEPTOR 5; ENZYME INHIBITOR; FLAVONOID; GADOLINIUM TEXAPHYRIN; GOLD COMPLEX; NITROSOUREA DERIVATIVE; ORGANOTELLURIUM DERIVATIVE; PHOSPHOLE DERIVATIVE; PLATINUM COMPLEX; POLYPHENOL DERIVATIVE; QUINONE DERIVATIVE; RESVERATROL; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE INHIBITOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

EID: 33751181030     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2006.09.004     Document Type: Review
Times cited : (310)

References (169)
  • 1
    • 0033775891 scopus 로고    scopus 로고
    • Physiological functions of thioredoxin and thioredoxin reductase
    • Arnér E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267 (2000) 6102-6109
    • (2000) Eur J Biochem , vol.267 , pp. 6102-6109
    • Arnér, E.S.1    Holmgren, A.2
  • 2
    • 0034652113 scopus 로고    scopus 로고
    • Thioredoxin reductase
    • Mustacich D., and Powis G. Thioredoxin reductase. Biochem J 346 Pt 1 (2000) 1-8
    • (2000) Biochem J , vol.346 , Issue.PART 1 , pp. 1-8
    • Mustacich, D.1    Powis, G.2
  • 3
    • 0032898734 scopus 로고    scopus 로고
    • Cloning, sequencing and functional expression of a novel human thioredoxin reductase
    • Gasdaska P.Y., Berggren M.M., Berry M.J., and Powis G. Cloning, sequencing and functional expression of a novel human thioredoxin reductase. FEBS Lett 442 (1999) 105-111
    • (1999) FEBS Lett , vol.442 , pp. 105-111
    • Gasdaska, P.Y.1    Berggren, M.M.2    Berry, M.J.3    Powis, G.4
  • 4
    • 0029142578 scopus 로고
    • Cloning and sequencing of a human thioredoxin reductase
    • Gasdaska P.Y., Gasdaska J.R., Cochran S., and Powis G. Cloning and sequencing of a human thioredoxin reductase. FEBS Lett 373 (1995) 5-9
    • (1995) FEBS Lett , vol.373 , pp. 5-9
    • Gasdaska, P.Y.1    Gasdaska, J.R.2    Cochran, S.3    Powis, G.4
  • 7
    • 0033609827 scopus 로고    scopus 로고
    • Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases
    • Sun Q.A., Wu Y., Zappacosta F., Jeang K.T., Lee B.J., Hatfield D.L., et al. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J Biol Chem 274 (1999) 24522-24530
    • (1999) J Biol Chem , vol.274 , pp. 24522-24530
    • Sun, Q.A.1    Wu, Y.2    Zappacosta, F.3    Jeang, K.T.4    Lee, B.J.5    Hatfield, D.L.6
  • 9
    • 0030588144 scopus 로고    scopus 로고
    • Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissue
    • Gasdaska J.R., Gasdaska P.Y., Gallegos A., and Powis G. Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissue. Genomics 37 (1996) 257-259
    • (1996) Genomics , vol.37 , pp. 257-259
    • Gasdaska, J.R.1    Gasdaska, P.Y.2    Gallegos, A.3    Powis, G.4
  • 10
    • 0024059244 scopus 로고
    • Ultrastructural demonstration of thioredoxin and thioredoxin reductase in rat hepatocytes
    • Rozell B., Holmgren A., and Hansson H.A. Ultrastructural demonstration of thioredoxin and thioredoxin reductase in rat hepatocytes. Eur J Cell Biol 46 (1988) 470-477
    • (1988) Eur J Cell Biol , vol.46 , pp. 470-477
    • Rozell, B.1    Holmgren, A.2    Hansson, H.A.3
  • 11
    • 0021810653 scopus 로고
    • Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats
    • Rozell B., Hansson H.A., Luthman M., and Holmgren A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol 38 (1985) 79-86
    • (1985) Eur J Cell Biol , vol.38 , pp. 79-86
    • Rozell, B.1    Hansson, H.A.2    Luthman, M.3    Holmgren, A.4
  • 12
    • 0034194276 scopus 로고    scopus 로고
    • Prominent expression of the selenoprotein thioredoxin reductase in the medullary rays of the rat kidney and thioredoxin reductase mRNA variants differing at the 5′ untranslated region
    • Rundlof A.K., Carlsten M., Giacobini M.M., and Arner E.S. Prominent expression of the selenoprotein thioredoxin reductase in the medullary rays of the rat kidney and thioredoxin reductase mRNA variants differing at the 5′ untranslated region. Biochem J 347 Pt 3 (2000) 661-668
    • (2000) Biochem J , vol.347 , Issue.PART 3 , pp. 661-668
    • Rundlof, A.K.1    Carlsten, M.2    Giacobini, M.M.3    Arner, E.S.4
  • 13
    • 0030020576 scopus 로고    scopus 로고
    • A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity
    • Tamura T., and Stadtman T.C. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA 93 (1996) 1006-1011
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 1006-1011
    • Tamura, T.1    Stadtman, T.C.2
  • 14
    • 0030499036 scopus 로고    scopus 로고
    • Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia
    • Berggren M., Gallegos A., Gasdaska J.R., Gasdaska P.Y., Warneke J., and Powis G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 16 (1996) 3459-3466
    • (1996) Anticancer Res , vol.16 , pp. 3459-3466
    • Berggren, M.1    Gallegos, A.2    Gasdaska, J.R.3    Gasdaska, P.Y.4    Warneke, J.5    Powis, G.6
  • 15
    • 0042807630 scopus 로고    scopus 로고
    • The thioredoxin-thioredoxin reductase system: over-expression in human cancer
    • Lincoln D.T., Ali Emadi E.M., Tonissen K.F., and Clarke F.M. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res 23 (2003) 2425-2433
    • (2003) Anticancer Res , vol.23 , pp. 2425-2433
    • Lincoln, D.T.1    Ali Emadi, E.M.2    Tonissen, K.F.3    Clarke, F.M.4
  • 16
    • 0035918571 scopus 로고    scopus 로고
    • Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma
    • Kahlos K., Soini Y., Saily M., Koistinen P., Kakko S., Paakko P., et al. Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma. Int J Cancer 95 (2001) 198-204
    • (2001) Int J Cancer , vol.95 , pp. 198-204
    • Kahlos, K.1    Soini, Y.2    Saily, M.3    Koistinen, P.4    Kakko, S.5    Paakko, P.6
  • 17
    • 0032552946 scopus 로고    scopus 로고
    • Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells
    • Gladyshev V.N., Factor V.M., Housseau F., and Hatfield D.L. Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells. Biochem Biophys Res Commun 251 (1998) 488-493
    • (1998) Biochem Biophys Res Commun , vol.251 , pp. 488-493
    • Gladyshev, V.N.1    Factor, V.M.2    Housseau, F.3    Hatfield, D.L.4
  • 18
    • 0034901958 scopus 로고    scopus 로고
    • Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma
    • Soini Y., Kahlos K., Napankangas U., Kaarteenaho-Wiik R., Saily M., Koistinen P., et al. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin Cancer Res 7 (2001) 1750-1757
    • (2001) Clin Cancer Res , vol.7 , pp. 1750-1757
    • Soini, Y.1    Kahlos, K.2    Napankangas, U.3    Kaarteenaho-Wiik, R.4    Saily, M.5    Koistinen, P.6
  • 19
    • 0347600941 scopus 로고    scopus 로고
    • Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events
    • Rundlof A.K., and Arner E.S. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events. Antioxid Redox Signal 6 (2004) 41-52
    • (2004) Antioxid Redox Signal , vol.6 , pp. 41-52
    • Rundlof, A.K.1    Arner, E.S.2
  • 20
    • 1642523633 scopus 로고    scopus 로고
    • Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma
    • Turunen N., Karihtala P., Mantyniemi A., Sormunen R., Holmgren A., Kinnula V.L., et al. Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. Apmis 112 (2004) 123-132
    • (2004) Apmis , vol.112 , pp. 123-132
    • Turunen, N.1    Karihtala, P.2    Mantyniemi, A.3    Sormunen, R.4    Holmgren, A.5    Kinnula, V.L.6
  • 21
    • 0033544915 scopus 로고    scopus 로고
    • Thioredoxin-dependent redox regulation of p53-mediated p21 activation
    • Ueno M., Masutani H., Arai R.J., Yamauchi A., Hirota K., Sakai T., et al. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem 274 (1999) 35809-35815
    • (1999) J Biol Chem , vol.274 , pp. 35809-35815
    • Ueno, M.1    Masutani, H.2    Arai, R.J.3    Yamauchi, A.4    Hirota, K.5    Sakai, T.6
  • 22
    • 20544433877 scopus 로고    scopus 로고
    • Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity
    • Seemann S., and Hainaut P. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity. Oncogene 24 (2005) 3853-3863
    • (2005) Oncogene , vol.24 , pp. 3853-3863
    • Seemann, S.1    Hainaut, P.2
  • 24
    • 0030731916 scopus 로고    scopus 로고
    • Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium
    • Gallegos A., Berggren M., Gasdaska J.R., and Powis G. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res 57 (1997) 4965-4970
    • (1997) Cancer Res , vol.57 , pp. 4965-4970
    • Gallegos, A.1    Berggren, M.2    Gasdaska, J.R.3    Powis, G.4
  • 25
    • 0032848137 scopus 로고    scopus 로고
    • Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase
    • Ganther H.E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20 (1999) 1657-1666
    • (1999) Carcinogenesis , vol.20 , pp. 1657-1666
    • Ganther, H.E.1
  • 26
    • 19944426986 scopus 로고    scopus 로고
    • Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation
    • Nalvarte I., Damdimopoulos A.E., Nystom C., Nordman T., Miranda-Vizuete A., Olsson J.M., et al. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation. J Biol Chem 279 (2004) 54510-54517
    • (2004) J Biol Chem , vol.279 , pp. 54510-54517
    • Nalvarte, I.1    Damdimopoulos, A.E.2    Nystom, C.3    Nordman, T.4    Miranda-Vizuete, A.5    Olsson, J.M.6
  • 27
    • 1642625262 scopus 로고    scopus 로고
    • Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group
    • Clark L.C., Combs Jr. G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276 (1996) 1957-1963
    • (1996) JAMA , vol.276 , pp. 1957-1963
    • Clark, L.C.1    Combs Jr., G.F.2    Turnbull, B.W.3    Slate, E.H.4    Chalker, D.K.5    Chow, J.6
  • 28
    • 33644655166 scopus 로고    scopus 로고
    • Antiglioma activity of 2,2′:6′2″-terpyridineplatinum(II) complexes in a rat model-effects on cellular redox metabolism
    • Ahmadi R., Urig S., Hartmann M., Helmke B.M., Koncarevic S., Allenberger B., et al. Antiglioma activity of 2,2′:6′2″-terpyridineplatinum(II) complexes in a rat model-effects on cellular redox metabolism. Free Radic Biol Med 40 (2006) 763-778
    • (2006) Free Radic Biol Med , vol.40 , pp. 763-778
    • Ahmadi, R.1    Urig, S.2    Hartmann, M.3    Helmke, B.M.4    Koncarevic, S.5    Allenberger, B.6
  • 29
    • 0037195158 scopus 로고    scopus 로고
    • Selenomethionine regulation of p53 by a ref1-dependent redox mechanism
    • Seo Y.R., Kelley M.R., and Smith M.L. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci USA 99 (2002) 14548-14553
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 14548-14553
    • Seo, Y.R.1    Kelley, M.R.2    Smith, M.L.3
  • 30
    • 0036604401 scopus 로고    scopus 로고
    • Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer
    • Mohler J.L., Morris T.L., Ford O.H., Alvey R.F., Sakamoto C., and Gregory C.W. Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. Prostate 51 (2002) 247-255
    • (2002) Prostate , vol.51 , pp. 247-255
    • Mohler, J.L.1    Morris, T.L.2    Ford, O.H.3    Alvey, R.F.4    Sakamoto, C.5    Gregory, C.W.6
  • 31
    • 27144473412 scopus 로고    scopus 로고
    • Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells
    • Gan L., Yang X.L., Liu Q., and Xu H.B. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells. J Cell Biochem 96 (2005) 653-664
    • (2005) J Cell Biochem , vol.96 , pp. 653-664
    • Gan, L.1    Yang, X.L.2    Liu, Q.3    Xu, H.B.4
  • 32
    • 33744958179 scopus 로고    scopus 로고
    • Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells
    • Yoo M.H., Xu X.M., Carlson B.A., Gladyshev V.N., and Hatfield D.L. Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J Biol Chem 281 (2006) 13005-13008
    • (2006) J Biol Chem , vol.281 , pp. 13005-13008
    • Yoo, M.H.1    Xu, X.M.2    Carlson, B.A.3    Gladyshev, V.N.4    Hatfield, D.L.5
  • 33
    • 0141676724 scopus 로고    scopus 로고
    • Thioredoxin reductase 1 expression in colon cancer: discrepancy between in vitro and in vivo findings
    • Lechner S., Muller-Ladner U., Neumann E., Spottl T., Schlottmann K., Ruschoff J., et al. Thioredoxin reductase 1 expression in colon cancer: discrepancy between in vitro and in vivo findings. Lab Invest 83 (2003) 1321-1331
    • (2003) Lab Invest , vol.83 , pp. 1321-1331
    • Lechner, S.1    Muller-Ladner, U.2    Neumann, E.3    Spottl, T.4    Schlottmann, K.5    Ruschoff, J.6
  • 34
    • 0035957325 scopus 로고    scopus 로고
    • Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems
    • Sun Q.A., Kirnarsky L., Sherman S., and Gladyshev V.N. Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc Natl Acad Sci USA 98 (2001) 3673-3678
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 3673-3678
    • Sun, Q.A.1    Kirnarsky, L.2    Sherman, S.3    Gladyshev, V.N.4
  • 35
    • 22544451578 scopus 로고    scopus 로고
    • Mammalian selenoprotein thioredoxin-glutathione reductase. Roles in disulfide bond formation and sperm maturation
    • Su D., Novoselov S.V., Sun Q.A., Moustafa M.E., Zhou Y., Oko R., et al. Mammalian selenoprotein thioredoxin-glutathione reductase. Roles in disulfide bond formation and sperm maturation. J Biol Chem 280 (2005) 26491-26498
    • (2005) J Biol Chem , vol.280 , pp. 26491-26498
    • Su, D.1    Novoselov, S.V.2    Sun, Q.A.3    Moustafa, M.E.4    Zhou, Y.5    Oko, R.6
  • 37
    • 0035793630 scopus 로고    scopus 로고
    • Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing
    • Sun Q.A., Zappacosta F., Factor V.M., Wirth P.J., Hatfield D.L., and Gladyshev V.N. Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. J Biol Chem 276 (2001) 3106-3114
    • (2001) J Biol Chem , vol.276 , pp. 3106-3114
    • Sun, Q.A.1    Zappacosta, F.2    Factor, V.M.3    Wirth, P.J.4    Hatfield, D.L.5    Gladyshev, V.N.6
  • 38
    • 1242338754 scopus 로고    scopus 로고
    • Evidence for intriguingly complex transcription of human thioredoxin reductase 1
    • Rundlof A.K., Janard M., Miranda-Vizuete A., and Arner E.S. Evidence for intriguingly complex transcription of human thioredoxin reductase 1. Free Radic Biol Med 36 (2004) 641-656
    • (2004) Free Radic Biol Med , vol.36 , pp. 641-656
    • Rundlof, A.K.1    Janard, M.2    Miranda-Vizuete, A.3    Arner, E.S.4
  • 39
    • 4644298932 scopus 로고    scopus 로고
    • Alternative splicing involving the thioredoxin reductase module in mammals: a glutaredoxin-containing thioredoxin reductase 1
    • Su D., and Gladyshev V.N. Alternative splicing involving the thioredoxin reductase module in mammals: a glutaredoxin-containing thioredoxin reductase 1. Biochemistry 43 (2004) 12177-12188
    • (2004) Biochemistry , vol.43 , pp. 12177-12188
    • Su, D.1    Gladyshev, V.N.2
  • 40
    • 4644313264 scopus 로고    scopus 로고
    • Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress
    • Smart D.K., Ortiz K.L., Mattson D., Bradbury C.M., Bisht K.S., Sieck L.K., et al. Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress. Cancer Res 64 (2004) 6716-6724
    • (2004) Cancer Res , vol.64 , pp. 6716-6724
    • Smart, D.K.1    Ortiz, K.L.2    Mattson, D.3    Bradbury, C.M.4    Bisht, K.S.5    Sieck, L.K.6
  • 41
    • 0242277285 scopus 로고    scopus 로고
    • The thioredoxin system-from science to clinic
    • Gromer S., Urig S., and Becker K. The thioredoxin system-from science to clinic. Med Res Rev 24 (2004) 40-89
    • (2004) Med Res Rev , vol.24 , pp. 40-89
    • Gromer, S.1    Urig, S.2    Becker, K.3
  • 43
    • 0030887844 scopus 로고    scopus 로고
    • The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli
    • Arscott L.D., Gromer S., Schirmer R.H., Becker K., and Williams Jr. C.H. The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci USA 94 (1997) 3621-3626
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 3621-3626
    • Arscott, L.D.1    Gromer, S.2    Schirmer, R.H.3    Becker, K.4    Williams Jr., C.H.5
  • 44
    • 0034674566 scopus 로고    scopus 로고
    • Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations
    • Zhong L., and Holmgren A. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J Biol Chem 275 (2000) 18121-18128
    • (2000) J Biol Chem , vol.275 , pp. 18121-18128
    • Zhong, L.1    Holmgren, A.2
  • 45
    • 0032103493 scopus 로고    scopus 로고
    • A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase
    • Gromer S., Wissing J., Behne D., Ashman K., Schirmer R.H., Flohe L., et al. A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem J 332 Pt 2 (1998) 591-592
    • (1998) Biochem J , vol.332 , Issue.PART 2 , pp. 591-592
    • Gromer, S.1    Wissing, J.2    Behne, D.3    Ashman, K.4    Schirmer, R.H.5    Flohe, L.6
  • 46
    • 0033775650 scopus 로고    scopus 로고
    • Thioredoxin reductase as a pathophysiological factor and drug target
    • Becker K., Gromer S., Schirmer R.H., and Muller S. Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem 267 (2000) 6118-6125
    • (2000) Eur J Biochem , vol.267 , pp. 6118-6125
    • Becker, K.1    Gromer, S.2    Schirmer, R.H.3    Muller, S.4
  • 48
    • 33751175035 scopus 로고    scopus 로고
    • Platinum(II) complexes: inhibition of thioredoxin reductase in glioblastoma therapy
    • Nishino R.M.T., Tanokura T., and Fukui K. (Eds), ARchiTect Inc., Tokyo
    • Urig S., Ahmadi R., Herold-Mende C., Alber D., and Becker K. Platinum(II) complexes: inhibition of thioredoxin reductase in glioblastoma therapy. In: Nishino R.M.T., Tanokura T., and Fukui K. (Eds). Flavins and Flavoproteins (2005), ARchiTect Inc., Tokyo 877-882
    • (2005) Flavins and Flavoproteins , pp. 877-882
    • Urig, S.1    Ahmadi, R.2    Herold-Mende, C.3    Alber, D.4    Becker, K.5
  • 49
    • 0032502720 scopus 로고    scopus 로고
    • Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue
    • Zhong L., Arn-er E.S., Ljung J., Aslund F., and Holmgren A. Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J Biol Chem 273 (1998) 8581-8591
    • (1998) J Biol Chem , vol.273 , pp. 8581-8591
    • Zhong, L.1    Arn-er, E.S.2    Ljung, J.3    Aslund, F.4    Holmgren, A.5
  • 50
    • 0035859927 scopus 로고    scopus 로고
    • Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme
    • Sandalova T., Zhong L., Lindqvist Y., Holmgren A., and Schneider G. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc Natl Acad Sci USA 98 (2001) 9533-9538
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 9533-9538
    • Sandalova, T.1    Zhong, L.2    Lindqvist, Y.3    Holmgren, A.4    Schneider, G.5
  • 51
    • 27244458231 scopus 로고    scopus 로고
    • Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism
    • Biterova E.I., Turanov A.A., Gladyshev V.N., and Barycki J.J. Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism. Proc Natl Acad Sci USA 102 (2005) 15018-15023
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 15018-15023
    • Biterova, E.I.1    Turanov, A.A.2    Gladyshev, V.N.3    Barycki, J.J.4
  • 52
    • 21144455675 scopus 로고    scopus 로고
    • The functional role of selenocysteine (Sec) in the catalysis mechanism of large thioredoxin reductases: proposition of a swapping catalytic triad including a Sec-His-Glu state
    • Brandt W., and Wessjohann L.A. The functional role of selenocysteine (Sec) in the catalysis mechanism of large thioredoxin reductases: proposition of a swapping catalytic triad including a Sec-His-Glu state. Chembiochem 6 (2005) 386-394
    • (2005) Chembiochem , vol.6 , pp. 386-394
    • Brandt, W.1    Wessjohann, L.A.2
  • 53
    • 0029051872 scopus 로고
    • Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide
    • Yokomizo A., Ono M., Nanri H., Makino Y., Ohga T., Wada M., et al. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 55 (1995) 4293-4296
    • (1995) Cancer Res , vol.55 , pp. 4293-4296
    • Yokomizo, A.1    Ono, M.2    Nanri, H.3    Makino, Y.4    Ohga, T.5    Wada, M.6
  • 55
    • 6344277918 scopus 로고    scopus 로고
    • Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function
    • Conrad M., Jakupoglu C., Moreno S.G., Lippl S., Banjac A., Schneider M., et al. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 24 (2004) 9414-9423
    • (2004) Mol Cell Biol , vol.24 , pp. 9414-9423
    • Conrad, M.1    Jakupoglu, C.2    Moreno, S.G.3    Lippl, S.4    Banjac, A.5    Schneider, M.6
  • 56
    • 20044378664 scopus 로고    scopus 로고
    • Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development
    • Jakupoglu C., Przemeck G.K., Schneider M., Moreno S.G., Mayr N., Hatzopoulos A.K., et al. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Mol Cell Biol 25 (2005) 1980-1988
    • (2005) Mol Cell Biol , vol.25 , pp. 1980-1988
    • Jakupoglu, C.1    Przemeck, G.K.2    Schneider, M.3    Moreno, S.G.4    Mayr, N.5    Hatzopoulos, A.K.6
  • 58
    • 0035397393 scopus 로고    scopus 로고
    • Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data
    • Cortes A., Cascante M., Cardenas M.L., and Cornish-Bowden A. Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochem J 357 (2001) 263-268
    • (2001) Biochem J , vol.357 , pp. 263-268
    • Cortes, A.1    Cascante, M.2    Cardenas, M.L.3    Cornish-Bowden, A.4
  • 59
    • 14944384045 scopus 로고    scopus 로고
    • Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes
    • Giovagnini L., Ronconi L., Aldinucci D., Lorenzon D., Sitran S., and Fregona D. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes. J Med Chem 48 (2005) 1588-1595
    • (2005) J Med Chem , vol.48 , pp. 1588-1595
    • Giovagnini, L.1    Ronconi, L.2    Aldinucci, D.3    Lorenzon, D.4    Sitran, S.5    Fregona, D.6
  • 60
    • 20144378947 scopus 로고    scopus 로고
    • Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase
    • Deponte M., Urig S., Arscott L.D., Fritz-Wolf K., Réau R., Herold-Mende C., et al. Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase. J Biol Chem 280 (2005) 20628-20637
    • (2005) J Biol Chem , vol.280 , pp. 20628-20637
    • Deponte, M.1    Urig, S.2    Arscott, L.D.3    Fritz-Wolf, K.4    Réau, R.5    Herold-Mende, C.6
  • 61
    • 0036688034 scopus 로고    scopus 로고
    • Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative
    • Rigobello M.P., Scutari G., Boscolo R., and Bindoli A. Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative. Br J Pharmacol 136 (2002) 1162-1168
    • (2002) Br J Pharmacol , vol.136 , pp. 1162-1168
    • Rigobello, M.P.1    Scutari, G.2    Boscolo, R.3    Bindoli, A.4
  • 62
    • 5344266051 scopus 로고    scopus 로고
    • Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions
    • Rigobello M.P., Messori L., Marcon G., Cinellu M.A., Bragadin M., Folda A., et al. Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions. J Inorg Biochem 98 (2004) 1634-1641
    • (2004) J Inorg Biochem , vol.98 , pp. 1634-1641
    • Rigobello, M.P.1    Messori, L.2    Marcon, G.3    Cinellu, M.A.4    Bragadin, M.5    Folda, A.6
  • 64
    • 0031984162 scopus 로고    scopus 로고
    • Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability
    • Rigobello M.P., Callegaro M.T., Barzon E., Benetti M., and Bindoli A. Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability. Free Radic Biol Med 24 (1998) 370-376
    • (1998) Free Radic Biol Med , vol.24 , pp. 370-376
    • Rigobello, M.P.1    Callegaro, M.T.2    Barzon, E.3    Benetti, M.4    Bindoli, A.5
  • 65
    • 0034705133 scopus 로고    scopus 로고
    • Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence
    • Zhong L., Arner E.S., and Holmgren A. Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence. Proc Natl Acad Sci USA 97 (2000) 5854-5859
    • (2000) Proc Natl Acad Sci USA , vol.97 , pp. 5854-5859
    • Zhong, L.1    Arner, E.S.2    Holmgren, A.3
  • 66
    • 0032493647 scopus 로고    scopus 로고
    • Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds
    • Gromer S., Arscott L.D., Williams Jr. C.H., Schirmer R.H., and Becker K. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem 273 (1998) 20096-20101
    • (1998) J Biol Chem , vol.273 , pp. 20096-20101
    • Gromer, S.1    Arscott, L.D.2    Williams Jr., C.H.3    Schirmer, R.H.4    Becker, K.5
  • 69
    • 0025062053 scopus 로고
    • The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase
    • Schallreuter K.U., Gleason F.K., and Wood J.M. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim Biophys Acta 1054 (1990) 14-20
    • (1990) Biochim Biophys Acta , vol.1054 , pp. 14-20
    • Schallreuter, K.U.1    Gleason, F.K.2    Wood, J.M.3
  • 70
    • 23444435104 scopus 로고    scopus 로고
    • Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds
    • Witte A.B., Anestal K., Jerremalm E., Ehrsson H., and Arner E.S. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. Free Radic Biol Med 39 (2005) 696-703
    • (2005) Free Radic Biol Med , vol.39 , pp. 696-703
    • Witte, A.B.1    Anestal, K.2    Jerremalm, E.3    Ehrsson, H.4    Arner, E.S.5
  • 72
    • 0642274801 scopus 로고    scopus 로고
    • Current chemotherapy for glioblastoma
    • Parney I.F., and Chang S.M. Current chemotherapy for glioblastoma. Cancer J 9 (2003) 149-156
    • (2003) Cancer J , vol.9 , pp. 149-156
    • Parney, I.F.1    Chang, S.M.2
  • 73
  • 74
    • 27244453860 scopus 로고    scopus 로고
    • The modulation of thiol redox state affects the production and metabolism of hydrogen peroxide by heart mitochondria
    • Rigobello M.P., Folda A., Scutari G., and Bindoli A. The modulation of thiol redox state affects the production and metabolism of hydrogen peroxide by heart mitochondria. Arch Biochem Biophys 441 (2005) 112-122
    • (2005) Arch Biochem Biophys , vol.441 , pp. 112-122
    • Rigobello, M.P.1    Folda, A.2    Scutari, G.3    Bindoli, A.4
  • 75
    • 22044444840 scopus 로고    scopus 로고
    • Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase
    • Rigobello M.P., Folda A., Baldoin M.C., Scutari G., and Bindoli A. Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase. Free Radic Res 39 (2005) 687-695
    • (2005) Free Radic Res , vol.39 , pp. 687-695
    • Rigobello, M.P.1    Folda, A.2    Baldoin, M.C.3    Scutari, G.4    Bindoli, A.5
  • 76
    • 33745221410 scopus 로고    scopus 로고
    • Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1)
    • [Epub ahead of print]
    • Omata Y., Folan M., Shaw M., Messer R.L., Lockwood P.E., Hobbs D., et al. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Toxicol In Vitro (2006) [Epub ahead of print]
    • (2006) Toxicol In Vitro
    • Omata, Y.1    Folan, M.2    Shaw, M.3    Messer, R.L.4    Lockwood, P.E.5    Hobbs, D.6
  • 77
    • 0037061638 scopus 로고    scopus 로고
    • Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties
    • Marcon G., Carotti S., Coronnello M., Messori L., Mini E., Orioli P., et al. Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties. J Med Chem 45 (2002) 1672-1677
    • (2002) J Med Chem , vol.45 , pp. 1672-1677
    • Marcon, G.1    Carotti, S.2    Coronnello, M.3    Messori, L.4    Mini, E.5    Orioli, P.6
  • 79
    • 33644855554 scopus 로고    scopus 로고
    • Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties
    • Ronconi L., Marzano C., Zanello P., Corsini M., Miolo G., Macca C., et al. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties. J Med Chem 49 (2006) 1648-1657
    • (2006) J Med Chem , vol.49 , pp. 1648-1657
    • Ronconi, L.1    Marzano, C.2    Zanello, P.3    Corsini, M.4    Miolo, G.5    Macca, C.6
  • 81
    • 18244379333 scopus 로고    scopus 로고
    • Cellular processing of platinum anticancer drugs
    • Wang D., and Lippard S.J. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4 (2005) 307-320
    • (2005) Nat Rev Drug Discov , vol.4 , pp. 307-320
    • Wang, D.1    Lippard, S.J.2
  • 82
    • 22144441320 scopus 로고    scopus 로고
    • Cisplatin damage: are DNA repair proteins saviors or traitors to the cell?
    • Zorbas H., and Keppler B.K. Cisplatin damage: are DNA repair proteins saviors or traitors to the cell?. Chembiochem 6 (2005) 1157-1166
    • (2005) Chembiochem , vol.6 , pp. 1157-1166
    • Zorbas, H.1    Keppler, B.K.2
  • 83
    • 0037430544 scopus 로고    scopus 로고
    • Interaction of binuclear xylylthiolato(2,2′,2″-terpyridine)platinum(II) complexes with DNA
    • Kurosaki H., Yamakawa N., Sumimoto M., Kimura K., and Goto M. Interaction of binuclear xylylthiolato(2,2′,2″-terpyridine)platinum(II) complexes with DNA. Bioorg Med Chem Lett 13 (2003) 825-828
    • (2003) Bioorg Med Chem Lett , vol.13 , pp. 825-828
    • Kurosaki, H.1    Yamakawa, N.2    Sumimoto, M.3    Kimura, K.4    Goto, M.5
  • 84
    • 27444435579 scopus 로고    scopus 로고
    • Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors
    • Millet R., Urig S., Jacob J., Amtmann E., Moulinoux J.P., Gromer S., et al. Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors. J Med Chem 48 (2005) 7024-7039
    • (2005) J Med Chem , vol.48 , pp. 7024-7039
    • Millet, R.1    Urig, S.2    Jacob, J.3    Amtmann, E.4    Moulinoux, J.P.5    Gromer, S.6
  • 85
    • 0035899183 scopus 로고    scopus 로고
    • Human thioredoxin reductase is efficiently inhibited by (2,2′:6′,2″- terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy
    • Becker K., Herold-Mende C., Park J.J., Lowe G., and Schirmer R.H. Human thioredoxin reductase is efficiently inhibited by (2,2′:6′,2″- terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy. J Med Chem 44 (2001) 2784-2792
    • (2001) J Med Chem , vol.44 , pp. 2784-2792
    • Becker, K.1    Herold-Mende, C.2    Park, J.J.3    Lowe, G.4    Schirmer, R.H.5
  • 86
    • 0037188214 scopus 로고    scopus 로고
    • Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs
    • Jansen B.A., Brouwer J., and Reedijk J. Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs. J Inorg Biochem 89 (2002) 197-202
    • (2002) J Inorg Biochem , vol.89 , pp. 197-202
    • Jansen, B.A.1    Brouwer, J.2    Reedijk, J.3
  • 87
    • 0030695172 scopus 로고    scopus 로고
    • Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo
    • Baker A., Payne C.M., Briehl M.M., and Powis G. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res 57 (1997) 5162-5167
    • (1997) Cancer Res , vol.57 , pp. 5162-5167
    • Baker, A.1    Payne, C.M.2    Briehl, M.M.3    Powis, G.4
  • 89
    • 0346398299 scopus 로고    scopus 로고
    • Double-drug development against antioxidant enzymes from Plasmodium falciparum
    • Biot C., Dessolin J., Grellier P., and Davioud-Charvet E. Double-drug development against antioxidant enzymes from Plasmodium falciparum. Redox Rep 8 (2003) 280-283
    • (2003) Redox Rep , vol.8 , pp. 280-283
    • Biot, C.1    Dessolin, J.2    Grellier, P.3    Davioud-Charvet, E.4
  • 90
    • 0034351135 scopus 로고    scopus 로고
    • Transfer of 4′-chloro-2,2′:6′,2″-terpyridine platinum(II) between human serum albumin, glutathione and other thiolate ligands. A possible selective natural transport mechanism for the delivery of platinum(II) drugs to tumour cells
    • Ross S.A., Carr C.A., Briet J.W., and Lowe G. Transfer of 4′-chloro-2,2′:6′,2″-terpyridine platinum(II) between human serum albumin, glutathione and other thiolate ligands. A possible selective natural transport mechanism for the delivery of platinum(II) drugs to tumour cells. Anticancer Drug Des 15 (2000) 431-439
    • (2000) Anticancer Drug Des , vol.15 , pp. 431-439
    • Ross, S.A.1    Carr, C.A.2    Briet, J.W.3    Lowe, G.4
  • 91
    • 0023190095 scopus 로고
    • New cisplatin analogies-on the way to better antitumor agents
    • Pasini A., and Zunino F. New cisplatin analogies-on the way to better antitumor agents. Angew Chem Int Ed Engl 26 (1987) 615-624
    • (1987) Angew Chem Int Ed Engl , vol.26 , pp. 615-624
    • Pasini, A.1    Zunino, F.2
  • 93
    • 0141811013 scopus 로고    scopus 로고
    • Recent developments in the field of tumor-inhibiting metal complexes
    • Galanski M., Arion V.B., Jakupec M.A., and Keppler B.K. Recent developments in the field of tumor-inhibiting metal complexes. Curr Pharm Des 9 (2003) 2078-2089
    • (2003) Curr Pharm Des , vol.9 , pp. 2078-2089
    • Galanski, M.1    Arion, V.B.2    Jakupec, M.A.3    Keppler, B.K.4
  • 94
    • 0034040527 scopus 로고    scopus 로고
    • An update on satraplatin: the first orally available platinum anticancer drug
    • Kelland L.R. An update on satraplatin: the first orally available platinum anticancer drug. Expert Opin Investig Drugs 9 (2000) 1373-1382
    • (2000) Expert Opin Investig Drugs , vol.9 , pp. 1373-1382
    • Kelland, L.R.1
  • 95
    • 33744986491 scopus 로고    scopus 로고
    • The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours
    • [Epub ahead of print]
    • Hall M.D., Alderden R.A., Zhang M., Beale P.J., Cai Z., Lai B., et al. The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours. J Struct Biol (2006) [Epub ahead of print]
    • (2006) J Struct Biol
    • Hall, M.D.1    Alderden, R.A.2    Zhang, M.3    Beale, P.J.4    Cai, Z.5    Lai, B.6
  • 96
    • 24944503564 scopus 로고    scopus 로고
    • The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes
    • Mellor H.R., Snelling S., Hall M.D., Modok S., Jaffar M., Hambley T.W., et al. The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes. Biochem Pharmacol 70 (2005) 1137-1146
    • (2005) Biochem Pharmacol , vol.70 , pp. 1137-1146
    • Mellor, H.R.1    Snelling, S.2    Hall, M.D.3    Modok, S.4    Jaffar, M.5    Hambley, T.W.6
  • 97
    • 5344277511 scopus 로고    scopus 로고
    • The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines
    • Hall M.D., Amjadi S., Zhang M., Beale P.J., and Hambley T.W. The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines. J Inorg Biochem 98 (2004) 1614-1624
    • (2004) J Inorg Biochem , vol.98 , pp. 1614-1624
    • Hall, M.D.1    Amjadi, S.2    Zhang, M.3    Beale, P.J.4    Hambley, T.W.5
  • 100
    • 0037366133 scopus 로고    scopus 로고
    • Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance
    • Fuertes M.A., Alonso C., and Perez J.M. Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev 103 (2003) 645-662
    • (2003) Chem Rev , vol.103 , pp. 645-662
    • Fuertes, M.A.1    Alonso, C.2    Perez, J.M.3
  • 101
    • 0022858683 scopus 로고
    • A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
    • Matsumura Y., and Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46 (1986) 6387-6392
    • (1986) Cancer Res , vol.46 , pp. 6387-6392
    • Matsumura, Y.1    Maeda, H.2
  • 102
    • 0026787767 scopus 로고
    • Cisplatin-albumin complex for treatment of cancer of the head and neck
    • Vreeburg G.C., Stell P.M., Holding J.D., and Lindup W.E. Cisplatin-albumin complex for treatment of cancer of the head and neck. J Laryngol Otol 106 (1992) 832-833
    • (1992) J Laryngol Otol , vol.106 , pp. 832-833
    • Vreeburg, G.C.1    Stell, P.M.2    Holding, J.D.3    Lindup, W.E.4
  • 103
    • 0034447210 scopus 로고    scopus 로고
    • Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells
    • Engman L., Kandra T., Gallegos A., Williams R., and Powis G. Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells. Anticancer Drug Des 15 (2000) 323-330
    • (2000) Anticancer Drug Des , vol.15 , pp. 323-330
    • Engman, L.1    Kandra, T.2    Gallegos, A.3    Williams, R.4    Powis, G.5
  • 104
    • 0037331676 scopus 로고    scopus 로고
    • Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants
    • Engman L., Al-Maharik N., McNaughton M., Birmingham A., and Powis G. Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants. Anticancer Drugs 14 (2003) 153-161
    • (2003) Anticancer Drugs , vol.14 , pp. 153-161
    • Engman, L.1    Al-Maharik, N.2    McNaughton, M.3    Birmingham, A.4    Powis, G.5
  • 105
    • 0242361208 scopus 로고    scopus 로고
    • Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells
    • Engman L., Al-Maharik N., McNaughton M., Birmingham A., and Powis G. Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells. Bioorg Med Chem 11 (2003) 5091-5100
    • (2003) Bioorg Med Chem , vol.11 , pp. 5091-5100
    • Engman, L.1    Al-Maharik, N.2    McNaughton, M.3    Birmingham, A.4    Powis, G.5
  • 106
    • 0346731228 scopus 로고    scopus 로고
    • Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth
    • McNaughton M., Engman L., Birmingham A., Powis G., and Cotgreave I.A. Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth. J Med Chem 47 (2004) 233-239
    • (2004) J Med Chem , vol.47 , pp. 233-239
    • McNaughton, M.1    Engman, L.2    Birmingham, A.3    Powis, G.4    Cotgreave, I.A.5
  • 107
    • 0041829414 scopus 로고    scopus 로고
    • A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines
    • Shi C., Yu L., Yang F., Yan J., and Zeng H. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines. Biochem Biophys Res Commun 309 (2003) 578-583
    • (2003) Biochem Biophys Res Commun , vol.309 , pp. 578-583
    • Shi, C.1    Yu, L.2    Yang, F.3    Yan, J.4    Zeng, H.5
  • 108
    • 33646097218 scopus 로고    scopus 로고
    • A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines
    • Zhao F., Yan J., Deng S., Lan L., He F., Kuang B., et al. A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines. Cancer Lett 236 (2006) 46-53
    • (2006) Cancer Lett , vol.236 , pp. 46-53
    • Zhao, F.1    Yan, J.2    Deng, S.3    Lan, L.4    He, F.5    Kuang, B.6
  • 109
    • 0028955626 scopus 로고
    • 1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity
    • Arnér E.S., Bjornstedt M., and Holmgren A. 1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity. J Biol Chem 270 (1995) 3479-3482
    • (1995) J Biol Chem , vol.270 , pp. 3479-3482
    • Arnér, E.S.1    Bjornstedt, M.2    Holmgren, A.3
  • 110
    • 0032080238 scopus 로고    scopus 로고
    • Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue
    • Nordberg J., Zhong L., Holmgren A., and Arner E.S. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J Biol Chem 273 (1998) 10835-10842
    • (1998) J Biol Chem , vol.273 , pp. 10835-10842
    • Nordberg, J.1    Zhong, L.2    Holmgren, A.3    Arner, E.S.4
  • 111
    • 0035584857 scopus 로고    scopus 로고
    • Reactive oxygen species, antioxidants, and the mammalian thioredoxin system
    • Nordberg J., and Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31 (2001) 1287-1312
    • (2001) Free Radic Biol Med , vol.31 , pp. 1287-1312
    • Nordberg, J.1    Arner, E.S.2
  • 112
    • 0032693662 scopus 로고    scopus 로고
    • Superoxide production by dinitrophenyl-derivatized thioredoxin reductase-a model for the mechanism and correlation to immunostimulation by dinitrohalobenzenes
    • Arnér E.S. Superoxide production by dinitrophenyl-derivatized thioredoxin reductase-a model for the mechanism and correlation to immunostimulation by dinitrohalobenzenes. Biofactors 10 (1999) 219-226
    • (1999) Biofactors , vol.10 , pp. 219-226
    • Arnér, E.S.1
  • 113
    • 33646806762 scopus 로고    scopus 로고
    • Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells
    • Cenas N., Prast S., Nivinskas H., Sarlauskas J., and Arner E.S. Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells. J Biol Chem 281 (2006) 5593-5603
    • (2006) J Biol Chem , vol.281 , pp. 5593-5603
    • Cenas, N.1    Prast, S.2    Nivinskas, H.3    Sarlauskas, J.4    Arner, E.S.5
  • 114
    • 1642535437 scopus 로고    scopus 로고
    • Interactions of quinones with thioredoxin reductase: a challenge to the antioxidant role of the mammalian selenoprotein
    • Cenas N., Nivinskas H., Anusevicius Z., Sarlauskas J., Lederer F., and Arner E.S. Interactions of quinones with thioredoxin reductase: a challenge to the antioxidant role of the mammalian selenoprotein. J Biol Chem 279 (2004) 2583-2592
    • (2004) J Biol Chem , vol.279 , pp. 2583-2592
    • Cenas, N.1    Nivinskas, H.2    Anusevicius, Z.3    Sarlauskas, J.4    Lederer, F.5    Arner, E.S.6
  • 115
    • 21644477778 scopus 로고    scopus 로고
    • Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity
    • Fang J., Lu J., and Holmgren A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem (2005)
    • (2005) J Biol Chem
    • Fang, J.1    Lu, J.2    Holmgren, A.3
  • 116
    • 33646233781 scopus 로고    scopus 로고
    • Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity
    • Lu J., Papp L.V., Fang J., Rodriguez-Nieto S., Zhivotovsky B., and Holmgren A. Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res 66 (2006) 4410-4418
    • (2006) Cancer Res , vol.66 , pp. 4410-4418
    • Lu, J.1    Papp, L.V.2    Fang, J.3    Rodriguez-Nieto, S.4    Zhivotovsky, B.5    Holmgren, A.6
  • 117
    • 33744956073 scopus 로고    scopus 로고
    • Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase
    • Hashemy S.I., Ungerstedt J.S., Avval F.Z., and Holmgren A. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J Biol Chem 281 (2006) 10691-10697
    • (2006) J Biol Chem , vol.281 , pp. 10691-10697
    • Hashemy, S.I.1    Ungerstedt, J.S.2    Avval, F.Z.3    Holmgren, A.4
  • 119
    • 33746110095 scopus 로고    scopus 로고
    • New principles in medicinal organometallic chemistry
    • Schatzschneider U., and Metzler-Nolte N. New principles in medicinal organometallic chemistry. Angew Chem Int Ed Engl 45 (2006) 1504-1507
    • (2006) Angew Chem Int Ed Engl , vol.45 , pp. 1504-1507
    • Schatzschneider, U.1    Metzler-Nolte, N.2
  • 122
    • 0346252644 scopus 로고    scopus 로고
    • Novel chemotherapeutic agents for the treatment of glioblastoma multiforme
    • Jendrossek V., Belka C., and Bamberg M. Novel chemotherapeutic agents for the treatment of glioblastoma multiforme. Expert Opin Investig Drugs 12 (2003) 1899-1924
    • (2003) Expert Opin Investig Drugs , vol.12 , pp. 1899-1924
    • Jendrossek, V.1    Belka, C.2    Bamberg, M.3
  • 123
    • 0032840612 scopus 로고    scopus 로고
    • Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum(II)
    • Sasada T., Nakamura H., Ueda S., Sato N., Kitaoka Y., Gon Y., et al. Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum(II). Free Radic Biol Med 27 (1999) 504-514
    • (1999) Free Radic Biol Med , vol.27 , pp. 504-514
    • Sasada, T.1    Nakamura, H.2    Ueda, S.3    Sato, N.4    Kitaoka, Y.5    Gon, Y.6
  • 124
    • 0037082122 scopus 로고    scopus 로고
    • Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species
    • Senturker S., Tschirret-Guth R., Morrow J., Levine R., and Shacter E. Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species. Arch Biochem Biophys 397 (2002) 262-272
    • (2002) Arch Biochem Biophys , vol.397 , pp. 262-272
    • Senturker, S.1    Tschirret-Guth, R.2    Morrow, J.3    Levine, R.4    Shacter, E.5
  • 125
    • 14044273000 scopus 로고    scopus 로고
    • Antiapoptotic response to induced GSH depletion: involvement of heat shock proteins and NF-kappaB activation
    • Filomeni G., Aquilano K., Rotilio G., and Ciriolo M.R. Antiapoptotic response to induced GSH depletion: involvement of heat shock proteins and NF-kappaB activation. Antioxid Redox Signal 7 (2005) 446-455
    • (2005) Antioxid Redox Signal , vol.7 , pp. 446-455
    • Filomeni, G.1    Aquilano, K.2    Rotilio, G.3    Ciriolo, M.R.4
  • 126
    • 2442464889 scopus 로고    scopus 로고
    • Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks
    • Pommier Y., Sordet O., Antony S., Hayward R.L., and Kohn K.W. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 23 (2004) 2934-2949
    • (2004) Oncogene , vol.23 , pp. 2934-2949
    • Pommier, Y.1    Sordet, O.2    Antony, S.3    Hayward, R.L.4    Kohn, K.W.5
  • 127
    • 2442689078 scopus 로고    scopus 로고
    • Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo
    • Sullivan A., Syed N., Gasco M., Bergamaschi D., Trigiante G., Attard M., et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23 (2004) 3328-3337
    • (2004) Oncogene , vol.23 , pp. 3328-3337
    • Sullivan, A.1    Syed, N.2    Gasco, M.3    Bergamaschi, D.4    Trigiante, G.5    Attard, M.6
  • 128
    • 0028568427 scopus 로고
    • The role of the p53 and Rb-1 genes in cancer, development and apoptosis
    • Hooper M.L. The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci Suppl 18 (1994) 13-17
    • (1994) J Cell Sci Suppl , vol.18 , pp. 13-17
    • Hooper, M.L.1
  • 130
    • 0033864687 scopus 로고    scopus 로고
    • A new resistance mechanism to cisplatin?
    • Kelland L.R. A new resistance mechanism to cisplatin?. Drug Resist Updat 3 (2000) 139-141
    • (2000) Drug Resist Updat , vol.3 , pp. 139-141
    • Kelland, L.R.1
  • 131
    • 1542787935 scopus 로고    scopus 로고
    • Intracavitary chemotherapy for glioblastoma: present status and future directions
    • Westphal M., Lamszus K., and Hilt D. Intracavitary chemotherapy for glioblastoma: present status and future directions. Acta Neurochir Suppl 88 (2003) 61-67
    • (2003) Acta Neurochir Suppl , vol.88 , pp. 61-67
    • Westphal, M.1    Lamszus, K.2    Hilt, D.3
  • 132
    • 3042848683 scopus 로고    scopus 로고
    • Cell death induction by betulinic acid, ceramide and TRAIL in primary glioblastoma multiforme cells
    • Jeremias I., Steiner H.H., Benner A., Debatin K.M., and Herold-Mende C. Cell death induction by betulinic acid, ceramide and TRAIL in primary glioblastoma multiforme cells. Acta Neurochir (Wien) 146 (2004) 721-729
    • (2004) Acta Neurochir (Wien) , vol.146 , pp. 721-729
    • Jeremias, I.1    Steiner, H.H.2    Benner, A.3    Debatin, K.M.4    Herold-Mende, C.5
  • 133
    • 0033572413 scopus 로고    scopus 로고
    • Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11
    • Gliniak B., and Le T. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. Cancer Res 59 (1999) 6153-6158
    • (1999) Cancer Res , vol.59 , pp. 6153-6158
    • Gliniak, B.1    Le, T.2
  • 134
    • 0034652486 scopus 로고    scopus 로고
    • Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
    • Nagane M., Pan G., Weddle J.J., Dixit V.M., Cavenee W.K., and Huang H.J. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res 60 (2000) 847-853
    • (2000) Cancer Res , vol.60 , pp. 847-853
    • Nagane, M.1    Pan, G.2    Weddle, J.J.3    Dixit, V.M.4    Cavenee, W.K.5    Huang, H.J.6
  • 135
    • 0034812659 scopus 로고    scopus 로고
    • Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety
    • Kelley S.K., Harris L.A., Xie D., Deforge L., Totpal K., Bussiere J., et al. Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety. J Pharmacol Exp Ther 299 (2001) 31-38
    • (2001) J Pharmacol Exp Ther , vol.299 , pp. 31-38
    • Kelley, S.K.1    Harris, L.A.2    Xie, D.3    Deforge, L.4    Totpal, K.5    Bussiere, J.6
  • 136
    • 0036341291 scopus 로고    scopus 로고
    • Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo
    • Fulda S., Wick W., Weller M., and Debatin K.M. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8 (2002) 808-815
    • (2002) Nat Med , vol.8 , pp. 808-815
    • Fulda, S.1    Wick, W.2    Weller, M.3    Debatin, K.M.4
  • 137
    • 0036215245 scopus 로고    scopus 로고
    • TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells
    • Beltinger C., Fulda S., Walczak H., and Debatin K.M. TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells. Cancer Gene Ther 9 (2002) 372-381
    • (2002) Cancer Gene Ther , vol.9 , pp. 372-381
    • Beltinger, C.1    Fulda, S.2    Walczak, H.3    Debatin, K.M.4
  • 139
    • 0026655577 scopus 로고
    • Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents
    • Britten R.A., Green J.A., and Warenius H.M. Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents. Int J Radiat Oncol Biol Phys 24 (1992) 527-531
    • (1992) Int J Radiat Oncol Biol Phys , vol.24 , pp. 527-531
    • Britten, R.A.1    Green, J.A.2    Warenius, H.M.3
  • 141
    • 0026459859 scopus 로고
    • The ATP-dependent glutathione S-conjugate export pump
    • Ishikawa T. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 17 (1992) 463-468
    • (1992) Trends Biochem Sci , vol.17 , pp. 463-468
    • Ishikawa, T.1
  • 142
    • 4344625883 scopus 로고    scopus 로고
    • A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells
    • Friesen C., Kiess Y., and Debatin K.M. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells. Cell Death Differ 11 (2004) S73-S85
    • (2004) Cell Death Differ , vol.11
    • Friesen, C.1    Kiess, Y.2    Debatin, K.M.3
  • 143
    • 0022537052 scopus 로고
    • Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs
    • Russo A., DeGraff W., Friedman N., and Mitchell J.B. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res 46 (1986) 2845-2848
    • (1986) Cancer Res , vol.46 , pp. 2845-2848
    • Russo, A.1    DeGraff, W.2    Friedman, N.3    Mitchell, J.B.4
  • 144
    • 4243524912 scopus 로고    scopus 로고
    • Potential for selective modulation of glutathione in cancer chemotherapy
    • Chen X., Carystinos G.D., and Batist G. Potential for selective modulation of glutathione in cancer chemotherapy. Chem Biol Interact 111-112 (1998) 263-275
    • (1998) Chem Biol Interact , vol.111-112 , pp. 263-275
    • Chen, X.1    Carystinos, G.D.2    Batist, G.3
  • 145
    • 14844293843 scopus 로고    scopus 로고
    • Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study
    • Mukherjee A., Westwell A.D., Bradshaw T.D., Stevens M.F., Carmichael J., and Martin S.G. Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study. Br J Cancer 92 (2005) 350-358
    • (2005) Br J Cancer , vol.92 , pp. 350-358
    • Mukherjee, A.1    Westwell, A.D.2    Bradshaw, T.D.3    Stevens, M.F.4    Carmichael, J.5    Martin, S.G.6
  • 146
    • 0032760588 scopus 로고    scopus 로고
    • Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake
    • Jiang C., Jiang W., Ip C., Ganther H., and Lu J. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinog 26 (1999) 213-225
    • (1999) Mol Carcinog , vol.26 , pp. 213-225
    • Jiang, C.1    Jiang, W.2    Ip, C.3    Ganther, H.4    Lu, J.5
  • 147
    • 0035679739 scopus 로고    scopus 로고
    • Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects
    • Lu J., and Jiang C. Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects. Nutr Cancer 40 (2001) 64-73
    • (2001) Nutr Cancer , vol.40 , pp. 64-73
    • Lu, J.1    Jiang, C.2
  • 148
    • 12744261583 scopus 로고    scopus 로고
    • Thioredoxin reductase regulates angiogenesis by increasing endothelial cell-derived vascular endothelial growth factor
    • Streicher K.L., Sylte M.J., Johnson S.E., and Sordillo L.M. Thioredoxin reductase regulates angiogenesis by increasing endothelial cell-derived vascular endothelial growth factor. Nutr Cancer 50 (2004) 221-231
    • (2004) Nutr Cancer , vol.50 , pp. 221-231
    • Streicher, K.L.1    Sylte, M.J.2    Johnson, S.E.3    Sordillo, L.M.4
  • 149
    • 27744567309 scopus 로고    scopus 로고
    • Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination-an effective strategy to improve clinical treatment
    • Lu da Y., Chen X.L., and Ding J. Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination-an effective strategy to improve clinical treatment. Med Hypotheses 66 (2006) 45-51
    • (2006) Med Hypotheses , vol.66 , pp. 45-51
    • Lu da, Y.1    Chen, X.L.2    Ding, J.3
  • 152
    • 27644554590 scopus 로고    scopus 로고
    • Individualised cancer therapeutics: dream or reality? Therapeutics construction
    • Shen Y., Senzer N., and Nemunaitis J. Individualised cancer therapeutics: dream or reality? Therapeutics construction. Expert Opin Biol Ther 5 (2005) 1427-1441
    • (2005) Expert Opin Biol Ther , vol.5 , pp. 1427-1441
    • Shen, Y.1    Senzer, N.2    Nemunaitis, J.3
  • 153
    • 0030873554 scopus 로고    scopus 로고
    • Schirmer RH and Becker K. The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase
    • Gromer S. Schirmer RH and Becker K. The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase. FEBS Lett 412 (1997) 318-320
    • (1997) FEBS Lett , vol.412 , pp. 318-320
    • Gromer, S.1
  • 154
    • 15944361817 scopus 로고    scopus 로고
    • Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity
    • Ronconi L., Giovagnini L., Marzano C., Bettio F., Graziani R., Pilloni G., et al. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity. Inorg Chem 44 (2005) 1867-1881
    • (2005) Inorg Chem , vol.44 , pp. 1867-1881
    • Ronconi, L.1    Giovagnini, L.2    Marzano, C.3    Bettio, F.4    Graziani, R.5    Pilloni, G.6
  • 155
    • 11344263608 scopus 로고    scopus 로고
    • Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma
    • Belani C.P. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma. Semin Oncol 31 (2004) 25-33
    • (2004) Semin Oncol , vol.31 , pp. 25-33
    • Belani, C.P.1
  • 156
    • 4544383470 scopus 로고    scopus 로고
    • Curcumin impairs tumor suppressor p53 function in colon cancer cells
    • Moos P.J., Edes K., Mullally J.E., and Fitzpatrick F.A. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 25 (2004) 1611-1617
    • (2004) Carcinogenesis , vol.25 , pp. 1611-1617
    • Moos, P.J.1    Edes, K.2    Mullally, J.E.3    Fitzpatrick, F.A.4
  • 157
    • 0037102391 scopus 로고    scopus 로고
    • Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points
    • Mehta M.P., Shapiro W.R., Glantz M.J., Patchell R.A., Weitzner M.A., Meyers C.A., et al. Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol 20 (2002) 3445-3453
    • (2002) J Clin Oncol , vol.20 , pp. 3445-3453
    • Mehta, M.P.1    Shapiro, W.R.2    Glantz, M.J.3    Patchell, R.A.4    Weitzner, M.A.5    Meyers, C.A.6
  • 158
    • 3042787102 scopus 로고    scopus 로고
    • Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial
    • Meyers C.A., Smith J.A., Bezjak A., Mehta M.P., Liebmann J., Illidge T., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22 (2004) 157-165
    • (2004) J Clin Oncol , vol.22 , pp. 157-165
    • Meyers, C.A.1    Smith, J.A.2    Bezjak, A.3    Mehta, M.P.4    Liebmann, J.5    Illidge, T.6
  • 159
    • 0030013113 scopus 로고    scopus 로고
    • Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI
    • Young S.W., Qing F., Harriman A., Sessler J.L., Dow W.C., Mody T.D., et al. Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI. Proc Natl Acad Sci USA 93 (1996) 6610-6615
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 6610-6615
    • Young, S.W.1    Qing, F.2    Harriman, A.3    Sessler, J.L.4    Dow, W.C.5    Mody, T.D.6
  • 160
    • 2942700238 scopus 로고    scopus 로고
    • Natural product based inhibitors of the thioredoxin-thioredoxin reductase system
    • Wipf P., Lynch S.M., Birmingham A., Tamayo G., Jimenez A., Campos N., et al. Natural product based inhibitors of the thioredoxin-thioredoxin reductase system. Org Biomol Chem 2 (2004) 1651-1658
    • (2004) Org Biomol Chem , vol.2 , pp. 1651-1658
    • Wipf, P.1    Lynch, S.M.2    Birmingham, A.3    Tamayo, G.4    Jimenez, A.5    Campos, N.6
  • 161
    • 27844503452 scopus 로고    scopus 로고
    • Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system
    • Wipf P., Lynch S.M., Powis G., Birmingham A., and Englund E.E. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system. Org Biomol Chem 3 (2005) 3880-3882
    • (2005) Org Biomol Chem , vol.3 , pp. 3880-3882
    • Wipf, P.1    Lynch, S.M.2    Powis, G.3    Birmingham, A.4    Englund, E.E.5
  • 162
    • 0037811713 scopus 로고    scopus 로고
    • Loss of selenium from selenoproteins: conversion of selenocysteine to dehydroalanine in vitro
    • Ma S., Caprioli R.M., Hill K.E., and Burk R.F. Loss of selenium from selenoproteins: conversion of selenocysteine to dehydroalanine in vitro. J Am Soc Mass Spectrom 14 (2003) 593-600
    • (2003) J Am Soc Mass Spectrom , vol.14 , pp. 593-600
    • Ma, S.1    Caprioli, R.M.2    Hill, K.E.3    Burk, R.F.4
  • 163
    • 0035152383 scopus 로고    scopus 로고
    • Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates
    • Rooseboom M., Commandeur J.N., Floor G.C., Rettie A.E., and Vermeulen N.P. Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates. Chem Res Toxicol 14 (2001) 127-134
    • (2001) Chem Res Toxicol , vol.14 , pp. 127-134
    • Rooseboom, M.1    Commandeur, J.N.2    Floor, G.C.3    Rettie, A.E.4    Vermeulen, N.P.5
  • 165
    • 0035890009 scopus 로고    scopus 로고
    • Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex
    • Arnér E.S., Nakamura H., Sasada T., Yodoi J., Holmgren A., and Spyrou G. Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex. Free Radic Biol Med 31 (2001) 1170-1178
    • (2001) Free Radic Biol Med , vol.31 , pp. 1170-1178
    • Arnér, E.S.1    Nakamura, H.2    Sasada, T.3    Yodoi, J.4    Holmgren, A.5    Spyrou, G.6
  • 167
    • 4644244279 scopus 로고    scopus 로고
    • Medicine. Targeting apoptotic pathways in cancer cells
    • Denicourt C., and Dowdy S.F. Medicine. Targeting apoptotic pathways in cancer cells. Science 305 (2004) 1411-1413
    • (2004) Science , vol.305 , pp. 1411-1413
    • Denicourt, C.1    Dowdy, S.F.2
  • 168
    • 0037013154 scopus 로고    scopus 로고
    • A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
    • Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109 (2002) 335-346
    • (2002) Cell , vol.109 , pp. 335-346
    • Schmitt, C.A.1    Fridman, J.S.2    Yang, M.3    Lee, S.4    Baranov, E.5    Hoffman, R.M.6
  • 169
    • 0034945142 scopus 로고    scopus 로고
    • Dissection the apoptotic mechanisms of chemotherapeutic drugs and lymphocytes to design effective anticancer drugs
    • Ruefli A.A., Davis J.E., Sutten V.R., Trapani J.A., Smyth M.J., and Johnstone R.W. Dissection the apoptotic mechanisms of chemotherapeutic drugs and lymphocytes to design effective anticancer drugs. Drug Dev Res 52 (2001) 549-557
    • (2001) Drug Dev Res , vol.52 , pp. 549-557
    • Ruefli, A.A.1    Davis, J.E.2    Sutten, V.R.3    Trapani, J.A.4    Smyth, M.J.5    Johnstone, R.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.